WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Ownership - Who owns Iovance Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iovance Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Finckenstein Friedrich GrafChief Medical Officer2026-06-053,976$4.23
$16.82kSell
Igor BilinskyChief Operating Officer2026-06-053,976$4.23
$16.82kSell
Raj K. PuriChief Regulatory Officer2026-06-053,843$4.23
$16.26kSell
Frederick G. VogtInterim CEO General Counsel2026-06-056,638$4.23
$28.08kSell
Frederick G. VogtInterim CEO General Counsel2026-06-0117,701$3.96
$70.10kSell
Igor BilinskyChief Operating Officer2026-06-014,473$3.96
$17.71kSell
Finckenstein Friedrich GrafChief Medical Officer2026-06-014,473$3.96
$17.71kSell
Raj K. PuriChief Regulatory Officer2026-06-012,508$3.96
$9.93kSell
Daniel Gordon KirbyChief Commercial Officer2026-05-112,435$3.70
$9.01kSell
Finckenstein Friedrich GrafChief Medical Officer2026-03-0516,520$4.58
$75.66kSell

1 of 3

IOVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IOVA insiders and whales buy or sell their stock.

IOVA Shareholders

What type of owners hold Iovance Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ayer Capital Management LP126.14%563,224,483$2.38BInsider
Paul L. Kessler93.07%415,566,430$1.76BInsider
Blackrock Inc6.96%31,080,505$131.47MInstitution
Mhr Fund Management LLC6.49%28,967,103$122.53MInstitution
Wayne P. Rothbaum6.29%28,067,333$118.72MInsider
Atlantic Hamilton4.69%20,960,016$88.66MInsider
David J. Voyticky4.25%18,981,082$80.29MInsider
State Street Corp3.91%17,448,108$73.81MInstitution
Vanguard Capital Management LLC3.72%16,617,737$70.29MInstitution
Two Sigma Investments LP3.07%13,687,433$57.90MInstitution

1 of 3

IOVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IOVA19.87%80.13%Net SellingNet Selling
ZYME51.33%48.67%Net BuyingNet Buying
RXRX63.44%13.64%Net SellingNet Selling
PGEN31.32%68.68%Net SellingNet Selling
URGN82.22%17.78%Net SellingNet Selling
View Top Biotech Stocks

Iovance Biotherapeutics Stock Ownership FAQ

Who owns Iovance Biotherapeutics?

Iovance Biotherapeutics (NASDAQ: IOVA) is owned by 60.24% institutional shareholders, 242.88% Iovance Biotherapeutics insiders, and 0.00% retail investors. Ayer Capital Management LP is the largest individual Iovance Biotherapeutics shareholder, owning 563.22M shares representing 126.14% of the company. Ayer Capital Management LP's Iovance Biotherapeutics shares are currently valued at $2.38B.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.